MMR, smoking, and 'in-vitro' models in COVID-19
Good summary of current science news topics for coronavirus in Reuters. Strong responders to MMR II vaccine (since 1979) have less severe disease with COVID-19, cigarette smoke increases risk, and a useful 'in-vivo' model for further study of how SARS-CoV-2 and other viruses might be treated.
Source: reuters.com
RSS feed